Presented
by

Presented by Oxford Global

Discover PLUS Pass

All Formulation & Delivery Content

Bringing you the latest research in drug formulation, drug delivery, bioanalysis and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Whitepaper
Solving Nanotechnology Application Challenges
Industry-leading Microfluidizer® processor technology for optimum performance and superior product quality.
02 October 2023
RNA Formulation & Delivery
Whitepaper
Fast-track Your Omics Data Analysis
From weeks to minutes with Omics Playground
02 October 2023
RNA Formulation & Delivery
Industry Spotlight
The Woman Who Changed the Course of the Pandemic: Katalin Karikó and the mRNA Revolution
Karikó's efforts and dedication have had a profound impact on the world, allowing us to navigate the pandemic with the help of mRNA vaccines.
Edited by Tom Cohen |
07 July 2023
RNA Formulation & Delivery
Whitepaper
Solving Nanotechnology Application Challenges
Industry-leading Microfluidizer® processor technology for optimum performance and superior product quality
23 June 2023
RNA Formulation & Delivery
Whitepaper
ChemGenes Corporation: Superior Quality RNA
23 June 2023
RNA Formulation & Delivery
Whitepaper
ChemGenes Corporation is now ISO 9001:2008 Certified Company
Product Highlight
23 June 2023
RNA Formulation & Delivery
Whitepaper
Fast-track Your Omics Data Analysis
From weeks to minutes with Omics Playground
23 June 2023
RNA Formulation & Delivery
Insight Article
Overcoming Challenges in Formulating and Delivering RNA Therapeutics: Insights from Formulation & Delivery US
What needs to be considered for RNA drug delivery? From the stability of LNPs, to proteins in the blood, to descant selection and packaging.
Edited by Tom Cohen |
17 May 2023
RNA Formulation & Delivery
Industry Spotlight
Spotlight on mRNA Vaccines: Made But Not Defined by the Pandemic
Where is the formulation and delivery of mRNA vaccines heading in the years after the pandemic?
Edited by Tom Cohen |
25 April 2023
RNA Formulation & Delivery
Insight Article
From LNPs to AAVs: Overcoming RNA Delivery Challenges
RNA therapeutics have great potential, as evidenced by the success of Pfizer-BioNTech and Moderna’s COVID vaccines. One difficulty that may stunt their success lies in their delivery challenges.
Edited by Tom Cohen |
08 September 2022
RNA Formulation & Delivery

Search by Keyword

Filter by Subject Area

Formulation & Delivery Series – Subject

Filter by Content Type

Resource Formats (incl. Industry Spotlight)

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.